MTA3 and nasopharyngeal carcinoma: A study using immunohistochemistry to assess MTA1, MTA2, and MTA3 expression in tissue microarrays from 152 patients with NPC demonstrated that MTA proteins are predominantly localized in the nucleus, and their associations with clinical parameters and prognosis exhibit ethnic variability.